Brivaracetam 25 mg

DRUG2 trials

Conditions

EpilepsyUnverricht-Lundborg Disease

Phase 3

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

CompletedNCT00357669

UCB Pharma SAUnverricht-Lundborg Disease

Start: 2006-11-30End: 2007-10-31Updated: 2015-05-18

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

CompletedNCT00464269

UCB PharmaEpilepsy

Start: 2007-09-30End: 2009-01-31Updated: 2022-07-21

2024-05-2910 citations

Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures.

2024-05-23

Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials.

2024-02-152 citations

Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials

Epilepsia2022-05-187 citations

Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis

Epilepsy Research2021-06-248 citations

Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis.

2021-06-21

Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial.

2020-12-0412 citations

Time course of drug-related treatment-emergent adverse side effects of brivaracetam.

2020-06-1412 citations

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial

Epilepsia2020-03-2833 citations

Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis.

2020-01-1230 citations

Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials.

2019-10-1410 citations

P.006 Efficacy of adjunctive brivaracetam in adult patients with secondarily generalized tonic-clonic seizures at baseline: pooled results from long-term follow-up trials

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques2019-06-01

Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.

2018-06-0414 citations

Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.

2018-02-0312 citations

Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.

2017-02-2727 citations

2017-02-238 citations

Time to onset of sustained ≥50% responder status in patients with focal (partial‐onset) seizures in three phase III studies of adjunctive brivaracetam treatment

Epilepsia2016-12-1833 citations

Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.

2016-09-0318 citations

Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies.

2016-08-1828 citations

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.

2016-06-2291 citations

9 more papers not shown

Brivaracetam 25 mg

Sponsors

Conditions

Phase 3

Related Papers